Related Experiment Videos
Sulfamylurea hypoglycemic agents. 6. High-potency derivatives.
Journal of Medicinal Chemistry
|May 1, 1976
Summary
New sulfamylurea derivatives show potent hypoglycemic activity, with specific acylaminoethyl substitutions enhancing blood sugar reduction. Gliamilide demonstrated good tolerability and a short plasma half-life in human trials.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Sulfonylureas are a class of oral hypoglycemic agents.
- Development of novel derivatives is crucial for improved efficacy and safety profiles.
Purpose of the Study:
- To synthesize novel sulfamylurea derivatives.
- To investigate the structure-activity relationships of these compounds for hypoglycemic effects.
Main Methods:
- Development of synthetic routes for novel sulfamylurea derivatives.
- Systematic modification of substituents at the piperidine ring and terminal urea nitrogen.
- Evaluation of hypoglycemic activity and pharmacokinetic properties.
Main Results:
- Enhanced hypoglycemic activity observed with acylaminoethyl functionalization at the piperidine ring.
- Identification of optimal acyl radicals (e.g., 5-chloro-2-methoxybenzoyl) and terminal urea substituents (e.g., cyclohexyl).
- Compound 81 (gliamilide) showed good human tolerability and a short plasma half-life.
Conclusions:
- Novel sulfamylurea derivatives possess significant hypoglycemic potential.
- Specific structural modifications can optimize antidiabetic activity.
- Gliamilide represents a promising candidate for further clinical development.